pyrroles has been researched along with entinostat in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bollard, CM; Buglio, D; Derenzini, E; Illés, A; Ji, Y; Jóna, A; Khaskhely, N; Medeiros, LJ; Shafer, JA; Younes, A | 1 |
| Bozzoni, I; Capogrossi, MC; Colussi, C; Farsetti, A; Gaetano, C; Mai, A; Martone, J; Nanni, S; Pontecorvi, A; Rosati, JD; Spallotta, F; Straino, S; Tardivo, S; Valente, S; Vecellio, M | 1 |
| Koppel, I; Timmusk, T | 1 |
| Hales, BF; Paradis, FH | 1 |
| Rajan, A; Shi, H; Xue, B | 1 |
| Bisagno, V; Garcia-Rill, E; Lee, SH; Mahaffey, S; Urbano, FJ | 1 |
| Kong, HH; Lee, HA; Moon, EK; Quan, FS | 1 |
| Bernardi, MA; Bisagno, V; Garcia-Rill, E; Sanz Blasco, S; Urbano, FJ | 1 |
| Chang, TY; Hsu, KC; Kaur, N; Lai, MJ; Lee, SB; Lin, TE; Liou, JP; Singh, A; Yen, Y | 1 |
| Bora, V; Goyal, RK; Johar, K; Patel, BM; Patel, D | 1 |
10 other study(ies) available for pyrroles and entinostat
| Article | Year |
|---|---|
The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors.
Topics: Acetylation; Apoptosis; Apoptosis Regulatory Proteins; Benzamides; Biphenyl Compounds; Boronic Acids; Bortezomib; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Hodgkin Disease; Humans; Indoles; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Nitrophenols; Piperazines; Protein Processing, Post-Translational; Pyrazines; Pyridines; Pyrroles; Sulfonamides; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein | 2011 |
Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia.
Topics: Animals; Benzamides; Dystrophin; Hindlimb; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Ischemia; Male; Mice; Muscle, Skeletal; Nitric Oxide Synthase Type I; Protein Phosphatase 2; Pyridines; Pyrroles; Regeneration; Time Factors | 2013 |
Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Topics: AIDS-Related Complex; Animals; Animals, Newborn; Benzamides; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Cycloheximide; Dose-Response Relationship, Drug; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Neurons; Proto-Oncogene Proteins c-fos; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Time Factors | 2013 |
The Effects of Class-Specific Histone Deacetylase Inhibitors on the Development of Limbs During Organogenesis.
Topics: Animals; Apoptosis; Benzamides; Biomarkers; Cells, Cultured; Chondrogenesis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type II; Collagen Type X; Embryo, Mammalian; Female; Forelimb; Gene Expression Regulation, Developmental; Genes, Reporter; Histone Deacetylase Inhibitors; Hydroxamic Acids; Luminescent Proteins; Mice, Transgenic; Naphthols; Osteogenesis; Pregnancy; Pyridines; Pyrroles; Recombinant Fusion Proteins; Teratogens | 2015 |
Class I and II Histone Deacetylase Inhibitors Differentially Regulate Thermogenic Gene Expression in Brown Adipocytes.
Topics: 3T3-L1 Cells; Acetylation; Adipocytes, Brown; Animals; Benzamides; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histones; Hydroxamic Acids; Mice; Pyridines; Pyrroles; Thermogenesis; Uncoupling Protein 1 | 2018 |
Class II histone deacetylases require P/Q-type Ca
Topics: Animals; Animals, Newborn; Benzamides; Benzylamines; Calcium Channels, P-Type; Calcium Channels, Q-Type; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Gamma Rhythm; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Indoles; Microtomy; Neurons; Pedunculopontine Tegmental Nucleus; Primary Cell Culture; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction; Sulfonamides; Tissue Culture Techniques; Transcription, Genetic | 2018 |
Histone Deacetylase Inhibitors Enhance the Amoebicidal Effect of Low Concentration of Polyhexamethylene Biguanide by Inducing Apoptosis.
Topics: Acanthamoeba castellanii; Annexin A5; Apoptosis; Benzamides; Biguanides; Cells, Cultured; Disinfectants; Drug Synergism; Epithelium, Corneal; Flow Cytometry; Fluorescein-5-isothiocyanate; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Pyridines; Pyrroles; Vorinostat | 2020 |
Differential effects of HDAC inhibitors on PPN oscillatory activity in vivo.
Topics: Animals; Benzamides; Female; Gamma Rhythm; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Male; Membrane Potentials; Neurons; Pedunculopontine Tegmental Nucleus; Pyridines; Pyrroles; Rats, Sprague-Dawley | 2020 |
CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibition.
Topics: Aminopyridines; Anilides; Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Protein Binding; Pyridines; Pyrimidines; Pyrroles; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2021 |
Systemic study of selected histone deacetylase inhibitors in cardiac complications associated with cancer cachexia.
Topics: Animals; Benzamides; Butyric Acid; Cachexia; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Female; Heart Diseases; Histone Deacetylase Inhibitors; Hydroxamic Acids; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Pyridines; Pyrroles | 2022 |